RNU6-860P

Q-omics provides the consensus-scored RNU6-860P profile across patient tissues and cancer cell-line models. RNU6-860P expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in KIRC. Additionally, RNU6-860P RNA expression shows 981 significant gene co-expression associations, with the highest sampling consensus in STAD. Together, these results highlight KIRC, and STAD as cancer lineages where RNU6-860P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes RNU6-860P survival associations across molecular data types. RNU6-860P RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RNU6-860P data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	1	KIRC (36)	view →

This table ranks reproducible RNU6-860P RNA expression–survival associations across cancer types. High RNU6-860P expression shows unfavorable associations in KIRC. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .018). Together, the overview and detailed table identify KIRC as the clearest survival context for RNU6-860P RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.279	0.805	.018	36	view →

Pink = unfavorable, green = favorable. all 1 lineages →

RNU6-860P-KIRC (OS)

Explore this curve interactively →